Performance of a new rapid test for detecting anti-hepatitis E virus immunoglobulin M in immunocompetent and immunocompromised patients

Journal of Clinical Virology

Volumn 70, Issue , 2015, Pages 101-104

  Abravanel, Florence ^a,b   Lhomme, Sébastien ^a,b   Chapuy Regaud, Sabine ^a,b   Peron, Jean Marie ^b   Alric, Laurent ^b   Rostaing, Lionel ^a,c   Kamar, Nassim ^a,c   Izopet, Jacques ^a,b  

^a INSERM   (France)

^b CHU PURPAN   (France)

^c CHU RANGUEIL   (France)

Author keywords

Hepatitis E virus; Immunochromatographis assay; Immunocompetent patients; Immunocompromised patients

Indexed keywords

HEPATITIS E ANTIBODY; VIRUS RNA; HEPATITIS ANTIBODY; IMMUNOGLOBULIN M;

ARTICLE; BLOOD SAMPLING; CLINICAL ARTICLE; CONTROLLED STUDY; CROSS REACTION; CYTOMEGALOVIRUS INFECTION; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; ENZYME IMMUNOASSAY; EPSTEIN BARR VIRUS INFECTION; HEPATITIS E VIRUS; HEPATITIS RAPID TEST; HUMAN; IMMUNOAFFINITY CHROMATOGRAPHY; IMMUNOCOMPROMISED PATIENT; LABORATORY DIAGNOSIS; PREDICTIVE VALUE; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; VIRUS DETECTION; BLOOD; ENZYME LINKED IMMUNOSORBENT ASSAY; FRANCE; GENETICS; HEPATITIS E; IMMUNOLOGY; PROCEDURES; REPRODUCIBILITY; STANDARDS; VIROLOGY;

ENZYME-LINKED IMMUNOSORBENT ASSAY; FRANCE; HEPATITIS ANTIBODIES; HEPATITIS E; HEPATITIS E VIRUS; HUMANS; IMMUNOCHROMATOGRAPHY; IMMUNOCOMPROMISED HOST; IMMUNOGLOBULIN M; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY;

EID: 84939631277     PISSN: 13866532     EISSN: 18735967     Source Type: Journal    
DOI: 10.1016/j.jcv.2015.07.302     Document Type: Article

References (32)

1. Abravanel F., Chapuy-Regaud S., Lhomme S., Dubois M., Peron J.M., Alric L., Rostaing L., Kamar N., Izopet J. Performance of two commercial assays for detecting HEV RNA in acute or chronic infections. J. Clin. Microbiol. 2013, Vol 51(6):1913-1916.
2. Abravanel F., Chapuy-Regaud S., Lhomme M., Peron L., Alric L., Kamar N., Izopet J. Performance of anti-HEV assays for diagnosing acute hepatitis E in immunocompromised patients. J. Clin. Virol. 2013, 58:624-628.
3. Abravanel F., Chapuy-Regaud S., Lhomme M., Peron L., Alric L., Kamar N., Izopet J. Performance of anti-HEV assays for diagnosing acute hepatitis E in immunocompromised patients. J. Clin. Virol. 2013, 58:624-628.
4. Abravanel F., Sandres-Saune K., Lhomme S., Dubois M., Mansuy J.M., Izopet J. Genotype 3 diversity and quantification of hepatitis E virus RNA. J. Clin. Microbiol. 2012, 50:897-902.
5. Aggarwal R., Shukla S., Jameel S., Agrawal P., Gupta V.K., Patil A.P., Naik S. T-cell epitope mapping of ORF2 and ORF3 proteins of human hepatitis E virus. J. Viral Hepat. 2007, 14:283-292.
6. CDC Investigation of hepatitis E outbreak among refugees-Upper Nile, South Sudan, 2012-2013. MMWR Morb. Mortal. Wkly. Rep. 2013, 62:581-586.
7. Chen HY, Lu Y, Howard T, Anderson D, Fong PY, Hu WP, Chia CP. Comparison of a new immunochromatographic test to enzyme-linked immunosorbent assay for rapid detection of immunoglobulin m antibodies to hepatitis E virus in human sera. Clin. Diagn. Lab. Immunol. 2005, 12:593-598.
8. Colson P., Kaba M., Moreau J., Brouqui P. Hepatitis E in an HIV-infected patient. J. Clin. Virol. 2009, 45:269-271.
9. Dalton H.R., Bendall R.P., Keane F.E., Tedder R.S., Ijaz S. Persistent carriage of hepatitis E virus in patients with HIV infection. N. Engl. J. Med. 2009, 361:1025-1027.
10. Dalton H.R., Thurairajah P.H., Fellows H.J., Hussaini J., Mitchell R., Bendall M., Banks S., Teo C.G., Levine D.F. Autochthonous hepatitis E in southwest England. J. Viral Hepat. 2007, 14:304-309.
11. Drobeniuc J., Meng G., Greene-Montfort N., Khudyakova Z., Kamili S., Teo C.G. Serologic assays specific to immunoglobulin M antibodies against hepatitis E virus: pangenotypic evaluation of performances. Clin. Infect. Dis. 2010, 51:e24-e27.
12. Fogeda M., de Ory F., Avellon A., Echevarria J.M. Differential diagnosis of hepatitis E virus, cytomegalovirus and Epstein-Barr virus infection in patients with suspected hepatitis E. J. Clin. Virol. 2009, 45:259-261.
13. Gerolami R., Moal Colson V.P. Chronic hepatitis E with cirrhosis in a kidney-transplant recipient. N. Engl. J. Med. 2008, 358:859-860.
14. Haagsma E.B., van Den Berg A.P., Porte R.J., Benne H., Reimerink J.H., Koopmans M.P. Chronic hepatitis E virus infection in liver transplant recipients. Liver Transpl. 2008, 14:547-553.
15. Hyams C., Mabayoje R., Copping D., Maranao M., Patel W., Haque T., Webster D.P. Serological cross reactivity to CMV and EBV causes problems in the diagnosis of acute hepatitis E virus infection. J. Med. Virol. 2014, 86:478-483.
16. Kamar N., Bendall R., Legrand-Abravanel F., Xia S., Izopet J., Dalton H.R. Hepatitis E. Lancet 2012, 379:2477-2488.
17. Kamar N., Dalton H.R., Abravanel F., Izopet J. Hepatitis E virus infection. Clin. Microbiol. Rev. 2014, 27:116-138.
18. Kamar N., Selves J., Mansuy L., Peron J., Guitard O., Cointault L., Esposito F., Abravanel M., Danjoux D., Vinel J.P., Izopet J., Rostaing L. Hepatitis E virus and chronic hepatitis in organ-transplant recipients. N. Engl. J. Med. 2008, 358:811-817.
19. Legrand-Abravanel F., Mansuy M., Dubois N., Peron J.M., Rostaing L., Izopet J. Hepatitis E virus genotype 3 diversity, France. Emerg. Infect. Dis. 2009, 15:110-114.
20. Legrand-Abravanel F., Thevenet I., Mansuy K., Saune F., Peron N., Rostaing L., Izopet J. Good performance of immunoglobulin M assays in diagnosing genotype 3 hepatitis E virus infections. Clin. Vaccine Immunol. 2009, 16:772-774.
21. Mansuy J.M., Huynh A., Abravanel F., Recher C., Peron J.M., Izopet J. Molecular evidence of patient-to-patient transmission of hepatitis E virus in a hematology ward. Clin. Infect. Dis. 2009, 48:373-374.
22. Meng J., Dai X., Chang E., Lopareva J., Fields H.A., Khudyakov Y.E. Identification and characterization of the neutralization epitope(s) of the hepatitis E virus. Virology 2001, 288:203-211.
23. Mengelle C., Sandres-Saune C., Pasquier L., Mansuy M., Da Silva M., Massip P., Izopet J. Automated extraction and quantification of human cytomegalovirus DNA in whole blood by real-time PCR assay. J. Clin. Microbiol. 2003, 41:3840-3845.
24. Myint K.S., Guan M., Chen Y., Lu D., Anderson T., Noedl H., Mammen M.P. Evaluation of a new rapid immunochromatographic assay for serodiagnosis of acute hepatitis E infection. Am. J. Trop. Med. Hyg. 2005, 73:942-946.
25. Ollier L., Tieulie F., Sanderson P., Heudier V., Fuzibet J.G., Nicand E. Chronic hepatitis after hepatitis E virus infection in a patient with non-Hodgkin lymphoma taking rituximab. Ann. Intern. Med. 2009, 150:430-431.
26. Parvez M.K., Ali R. Hepatitis E virus cross-reactivity and false-seropositivity: challenges to diagnosis. J. Liver 2014, 3:e109.
27. Pas S.D., Streefkerk M., de Man R.A., Beersma M.F., Osterhaus A.D., van der Eijk A.A. Diagnostic performance of selected commercial HEV IgM and IgG ELISAs for immunocompromised and immunocompetent patients. J. Clin. Virol. 2013, 58:629-634.
28. Peron J.M., Mansuy J.M., Poirson H., Bureau C., Dupuis E., Alric L., Izopet J., Vinel J.P. Hepatitis E is an autochthonous disease in industrialized countries. Analysis of 23 patients in South-West France over a 13-month period and comparison with hepatitis A. Gastroenterol. Clin. Biol. 2006, 30:757-762.
29. Purcell R.H., Emerson S.U. Hepatitis E: an emerging awareness of an old disease. J. Hepatol. 2008, 48:494-503.
30. Rein D.B., Stevens G.A., Theaker J., Wittenborn J.S., Wiersma S.T. The global burden of hepatitis E virus genotypes 1 and 2 in 2005. Hepatology 2005, 55:988-997.
31. Schnegg A., Burgisser C., Kenfak-Foguena G., Canellini D., Moradpour F., Abravanel J., Cavassini M., Darling K.E. An analysis of the benefit of using hev genotype 3 antigens in detecting Anti-HEV IgG in a European population. PLoS One 2013, 8:e62980.
32. Tavitian S., Peron A., Mansuy L., Ysebaert F., Vinel M., Izopet J., Recher C. Hepatitis E virus excretion can be prolonged in patients with hematological malignancies. J. Clin. Virol. 2010, 49:141-144.